RE: 910k buy there5 Mar 2024 19:26
There absolutely is Gheko, the surprise is FAB remains at this low valuation. A NCI deal would not occur on a whim. The micro cap at the moment is two edged. The fixed costs involved of for example travel and participation in overseas exhibitions/scientific conferences + salaries already would erode quite a bit of the financial resources. Yet royalties and income from agreements could be hugely transformative with the current valuation so minuscule. So I see great risk-reward potential, although still definitely work to do